Reducing Readmissions for Cancer Patients with Telemedicine and Integrative Care
Official title: Reducing ReADmissions through Innovative ApplicatioNs of Telemedicine (RADIANT)
Funded at Sloan-Kettering Inst Can Research · NIH-11298101 · Data updated 2026-11-12
A cancer patient-centered program tests a telemedicine approach with remote monitoring and integrative therapies to help cancer patients stay out of the hospital after discharge.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | June 2, 2026 |
| Project end | May 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $747,660 |
| NIH project number | 1R37CA300137-01A1 |
| Project ID | NIH-11298101 on NIH RePORTER |
Who could benefit from this research
✓Could help
Medical oncology patients recently discharged from hospital who have the potential to participate in telemedicine-based RPM and IM interventions.
✕Less likely to help
Patients with types of cancer or clinical scenarios not suitable for remote monitoring or those who cannot access telemedicine services may see limited or no benefit.
What this research studies
This project tests a scalable telemedicine platform that combines remote symptom monitoring with integrative medicine to support medical oncology patients after hospital discharge. Patients use electronic patient-reported outcomes to track symptoms, and the system provides timely interventions to prevent readmission. The goal is to reduce 12-week readmissions while addressing barriers to access for exercise and mind-body therapies, such as cost and transportation. The study builds on a prior pilot and aims to demonstrate feasibility, safety, and potential impact in real-world clinical settings. Results could guide future adoption of RPM and integrative care to improve quality of life and reduce costs for patients and caregivers.
Why it matters
Potential benefit: Potentially fewer hospital readmissions and improved symptom control for cancer patients after discharge.
How similar studies have gone: A prior pilot randomized trial suggested feasibility and potential benefit of telemedicine for integrative care in this setting.
Where this research is happening
-
Sloan-Kettering Inst Can Research
New York, United States Active
Researchers
- Principal investigator: Daly, Robert Michael — Sloan-Kettering Inst Can Research
- Study coordinator: Daly, Robert Michael
Related research
Other NIH-funded projects on the same topics.
-
Improving after-hours pediatric care with a telemedicine and medicine-delivery tool using smart technology
A pediatric telemedicine and medication delivery service is being improved with smart tools to help kids get quick after-hours care, especially when a clinic is closed.
-
Telemedicine to boost heart failure guideline therapy in rural patients
This project tests whether telemedicine can help rural heart failure patients receive the right heart failure medicines and improve health outcomes.
-
Enhanced primary care telemedicine for kids with lung and airway infections
A pediatric-focused telemedicine program is being studied to reduce unnecessary antibiotic use for common respiratory infections in children.
-
Buprenorphine options via telemedicine for people leaving jail
A patient-centered study will let adults leaving Maryland jails choose between two forms of buprenorphine, to be taken remotely with telemedicine and pharmacy support.
-
Teleneonatology: Telemedicine for improving resuscitation of at-risk newborns in community hospitals
A nationwide study tests real-time telemedicine help from neonatologists to support delivery-room care for newborns who struggle to breathe at birth, especially in hospitals without NICUs.
-
Improving after-hours pediatric care with telemedicine and medication delivery using smart tools
A pediatric telemedicine and medication delivery program is being developed to help kids get faster care after hours using an electronic decision tool and a smarter triage system.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.